Innovation1 Biotech Inc. (IVBT)
| Market Cap | 112.35K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.21M |
| Shares Out | 22.47M |
| EPS (ttm) | -0.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 220 |
| Average Volume | 126 |
| Open | 0.0050 |
| Previous Close | 0.0050 |
| Day's Range | 0.0050 - 0.0050 |
| 52-Week Range | 0.0002 - 0.0050 |
| Beta | 5.83 |
| RSI | 94.94 |
| Earnings Date | Jul 11, 2025 |
About Innovation1 Biotech
Innovation1 Biotech Inc., does not have significant operations. Previously, it was focused on the development of modified schedule 1 molecules of botanical origin in the United States. The company was founded in 2014 and is based in Somerville, Massachusetts. [Read more]
Financial Performance
Financial StatementsNews
Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors
NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of mo...
Innovation1 Biotech Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction
NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of mod...
Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D.
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of modi...
Innovation1 Biotech (IVBT) Completes Name and Ticker Symbol Change from Gridiron BioNutrients (GMVP)
NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of mod...